Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

vTv Therapeutics Inc

http://vtvtherapeutics.com/

Latest From vTv Therapeutics Inc

Lilly Tries New Neuro Approach With Disarm Buyout

Deal Snapshot: Lilly bets $135m on biotech’s preclinical SARM1 inhibitor program, seeing potential in peripheral neuropathy and possibly some bigger targets in neurology like MS and ALS.

M & A Deals

Finance Watch: VC Mega-Rounds For Machine Learning, CNS Disorders, Academic Discoveries

Private Company Edition: Arvelle, insitro, AbCellera and the University of Michigan have something in common – they each attracted more than $100m in venture capital investment.

Financing StartUps and SMEs

Study Recommends Hydrogen Peroxide For N95 Decontamination

Research suggests N95 respirators used by medical staff can be safely decontaminated at least two to three times, with hydrogen peroxide vapor the most effective decontamination method.

Research & Development Safety

New Phase II Data Bolster vTv Therapeutics’ Glucokinase Activator Aspirations

The future for glucokinase activation is looking brighter after fresh data on vTv’s oral adjunct to insulin therapy in type 1 diabetes.

Clinical Trials Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • TransTech Pharma, Inc.
UsernamePublicRestriction

Register